National Jewish Health
Dr. Taylor-Cousar is a tenured professor of adult and pediatric pulmonary medicine at National Jewish Health (NJH), where she serves as the Medical Director of Clinical Research Services, President of the Medical Staff, and is co-director of the Adult CF Program and Director of the CF Therapeutics Development Network (TDN) Center. She received her undergraduate degree in human biology from Stanford University in 1993, and completed her doctorate in medicine in 1998, combined residency in internal medicine and pediatrics in 2002, and her combined fellowship in adult and pediatric pulmonary medicine in 2006 at Duke University Medical Center. She obtained her Master of Clinical Science from the University of Colorado in 2015.
She has been site primary investigator on more than 60 clinical studies, and national/global primary investigator on 5 clinical trials.Her investigator initiated research focuses on the development and evaluation of novel therapies for the treatment of CF, and on reproductive health in people with CF in the CFTR modulator era. She is also investigating the etiology and treatment of bronchiectasis in non-human primates. She has published more than 130 manuscripts as well as a book and multiple book chapters, and is an elected member of the American Society for Clinical Investigation (2020).
Dr. Taylor-Cousar serves on numerous local and national committees including as a member of the NIH Clinical Trials Study section and the scientific advisory board for Emily's Entourage. She also serves as the Adult Care Representative to the Cystic Fibrosis Foundation’s (CFF) Board of Trustees, on the CFF’s Clinical Research Advisory Board, the CF TDN’s Clinical Research Executive Committee and as Immediate Past Chair of the CF TDN’s Sexual Health, Reproduction and Gender Research Working Group. She is an Associate Editor for the Journal of Cystic Fibrosis and a member of the International Advisory Board for the Lancet Respiratory Medicine. She is Chair-elect of the American Thoracic Society (ATS) International Conference Committee. She has co-chaired numerous sessions and given invited lectures at the ATS International Conference, the TSANZ International Conference, and the North American, European, Israeli, Mexican, Spanish and Australian CF Conferences, as well as at regional CF and pulmonary conferences and national and international veterinary conferences. She is an active member of the Colorado Chapter CF Board.
Dr. Taylor-Cousar is a staunch advocate for racial justice both in academic medicine and for people with CF. She was one of the founding members of the NJH Diversity, Equity and Inclusion (DEI) council (2015) and served for two years as the NJH interim Associate Vice President of DEI. Beyond NJH, she is a member of the CFF’s Racial Justice Working Group, Co-Chair of the of the CFF Health Equity Team Science Award study section, a member of the ATS Workshop on Research Priorities in Pediatric Asthma: Addressing Systemic Racism, and an external advisory member for the NIH P30 Georgia CF Core Center focus on Achieving Health Equity in CF Care and Research. She has also partnered with several CF patient organizations to increase awareness of the occurrence of CF in people of color.
S11--Nucleotide-Based Therapeutics Across Diverse Populations
Thursday, September 26, 2024
2:30 PM – 4:30 PM ET
S25.3- Ongoing Barriers to Exercise in the CFTR Modulator Era
Saturday, September 28, 2024
10:15 AM – 12:15 PM ET